Navigation Links
U.S. Advisers Say It's Now Safe to Publish Bird Flu Studies
Date:3/31/2012

SATURDAY, March 31 (HealthDay News) -- Research on a mutated, more contagious form of the bird flu virus can be published in full, U.S. government biosecurity advisers said Friday, despite initial concerns that bioterrorists could use the information to start a pandemic.

The National Science Advisory Board for Biosecurity said two research papers, which have been revised since they were first offered for publication late last year, have been reworked enough so they no longer contain details that might be of value to bioterrorists. The advisers' recommendation now goes to the U.S. Department of Health and Human Services for a decision, the Associated Press reported.

In December, the advisers recommended against publication of the papers because doing so was potentially risky.

The two studies at the center of the debate were to be published in the journals Science and Nature late last year. The papers, which were funded by the U.S. National Institutes of Health, describe how the virus could mutate relatively easily into a strain that could spread rapidly among humans. The research was done by scientists at the University of Wisconsin and in the Netherlands.

Although the bird flu virus, known as H5N1, rarely infects people, it appears to be highly lethal when it does. Of about 600 known cases, more than half have been fatal. If the virus were able to spread more easily from birds to humans, experts have estimated that millions of people could die after being infected.

Friday's recommendation could end a debate that involved scientists worldwide. Many contended that full publication of the two papers would help scientists monitor potentially dangerous mutations in bird flu viruses that circulate naturally. The papers could also help test vaccines and treatments for a mutated form of the bird flu, some scientists said, the AP reported.

In February, the World Health Organization made a similar recommendation to publish the studies after a special meeting of 22 bird flu experts in Geneva, Switzerland. The meeting was convened by the WHO to discuss the "urgent issues" that have swirled around possible publication of the two bird flu studies since last November, The New York Times reported.

Most of those at the Geneva meeting felt that any theoretical terrorist risk was outweighed by the "real and present danger" of similar flu virus mutations occurring naturally in the wild, and by the need for the scientific community to share information that could help identify exactly when the virus might be developing the ability to spread more easily, Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, told the Times. Fauci represented the United States at the meeting.

The editors of both journals said they plan to publish the papers in full at a future date.

More information

For more on how the bird flu virus might be able to infect humans, visit the U.S. National Institute of Allergy and Infectious Diseases.

-- HealthDay staff

SOURCES: Associated Press; The New York Times


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. U.S. Advisers Explain Request to Censor Bird Flu Research
2. FDA Advisers: Newer Forms of the Pill Need Revised Warning Labels
3. FDA Advisers Call for Revised Labels for Osteoporosis Drugs
4. FDA Advisers Urge Infant Doses for Kids OTC Fever Relievers
5. FDA Advisers Renew Review on Whether to Ban Menthol Cigarettes
6. FDA Advisers Endorse New Lupus Drug
7. FDA Advisers Consider New Lupus Drug
8. FDA Advisers Back Anemia Drugs for Kidney Patients
9. FDA Advisers Consider Approval of Genetically Modified Salmon
10. FDA Advisers Weigh Approval of Genetically Modified Salmon
11. FDA Advisers Divided on Whether to Ban Diet Drug Meridia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center for ... Table in Battle Creek, MI, where the rehabilitation facility is located. This annual celebration ... world’s leading providers of cereal and other breakfast foods. Its residents often refer to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: